NAUT
Nautilus Biotechnology, Inc.
Set alert
2.73 USD -0.41 -13.06%
2.64 Day range 3.08
0.852 52-week range 3.95
- YTD
- +40.00%
- 1 year
- +93.62%
- Open
- 2.88
- Prev close
- 3.14
- Mkt cap
- 347.73M
- Vol
- 8.07M
- Avg vol
- 5.24M
- EPS
- -0.46
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.64
- High
- 3.08
- Forward P/E
- -2.32
- Beta
- 1.04
- Short ratio
- 9.26
- Inst. own
- 50.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 30, 2024
- 50-d avg
- 2.42
- 200-d avg
- 2.56
- 1y target
- 3.44
Financial health
Altman Z-Score
2.23 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 4
Valuation
P/E -4.1×
FY 2018 5y median -4.1× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 1.6×
FY 2018 5y median 1.2× FY 2025
P/FCF -4.7×
FY 2018 5y median -4.7× FY 2025
EV/EBITDA -5.0×
FY 2018 5y median -5.0× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -21.1%
FY 2018 5y median -21.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -37.6%
FY 2018 5y median -24.0% FY 2025
ROIC -35.7%
FY 2018 5y median -25.4% FY 2025
ROA -30.9%
FY 2018 5y median -20.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 18.0%
FY 2018 FY 2025
EPS (diluted) 16.1%
FY 2018 FY 2025
Free Cash Flow 15.2%
FY 2018 FY 2025
Financial Health
Current Ratio 13.3×
FY 2018 5y median 19.4× FY 2025
Quick Ratio 13.3×
FY 2018 5y median 19.4× FY 2025
Debt / Equity 0.2×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA -0.3×
FY 2018 5y median -0.0× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31